Therapy for Dupuytren's Disease (II): Collagenase Therapy vs. Limited Fasciectomy-A Long-Term Comparative Study

被引:0
作者
Wachtel, Nikolaus [1 ]
Dingler, Francesca Romana [1 ]
Kuhlmann, Constanze [1 ]
Mert, Sinan [1 ]
Haas-Luetzenberger, Elisabeth Maria [1 ]
Alt, Verena [1 ]
Moellhoff, Nicholas [1 ]
Giunta, Riccardo [1 ]
Demmer, Wolfram [1 ]
机构
[1] LMU Klinikum, Dept Hand Plast & Aesthet Surg, Ziemssenstr 5, D-80336 Munich, Germany
来源
LIFE-BASEL | 2025年 / 15卷 / 01期
关键词
Dupuytren's disease; palmar fascial fibromatosis; Viking disease; contracture; collagenase; Xiapex; limited fasciectomy; PERCUTANEOUS NEEDLE APONEUROTOMY; CLOSTRIDIUM-HISTOLYTICUM; NONSURGICAL TREATMENT; CONTRACTURE; INJECTION; RELIABILITY; PREVALENCE; FASCIOTOMY; RECURRENCE; STRENGTH;
D O I
10.3390/life15010076
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Dupuytren's disease (DD) is a systemic connective tissue disorder of the palm, predominantly affecting men of Northern European or Caucasian origin over 55. In addition to conventional surgery, Dupuytren's contracture can be treated in a minimally invasive way by injecting bacterial collagenase into the cord. However, studies on the long-term success rate when compared to the gold standard, surgical limited fasciectomy, are limited. Methods: This monocentric retrospective study examined 35 patients who had been treated with bacterial collagenase for Dupuytren's contracture, conducting a long-term follow-up after an average of 5.7 years. The results were compared to a control group of 40 patients treated with surgical limited fasciectomy on average 5.5 years ago. Finger extension (Tubiana stage), strength, sensitivity, the effect of possible risk factors, and patient-reported outcome measures (PROMs) were compared between the two groups. Results: The long-term results after therapy for DD showed a significant reduction in the Tubiana stage for both groups (p < 0.001). Additionally, we observed a longer mean preintervention Tubiana stage and a better long-term improvement in the Tubiana stage for patients with limited fasciectomy when compared to the collagenase group. (both p < 0.001). Neither grip strength nor the pinch test showed significant differences when compared within each group or when comparing both groups. Both the treated and untreated fingers of patients with limited fasciectomy had a superior two-point discrimination (p < 0.001). For the URAM questionnaire, we observed a significantly better result in the control group (p < 0.01). Retrospectively, significantly more patients in the collagenase group would not choose the same therapy to treat DD (35 vs. 8%; p < 0.05). Conclusions: The two therapy options should be seen as complementary for the treatment of DD. Collagenase therapy seems a sensible option for DD with an earlier Tubiana stage and contractures that predominantly affect the MCP joint. Contractures with higher Tubiana stages that also affect the PIP joint should predominantly be treated with limited fasciectomy.
引用
收藏
页数:13
相关论文
共 64 条
  • [1] Comparing Complications and Patient Satisfaction Following Injectable Collagenase Versus Limited Fasciectomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis
    Alhebshi, Zainah A.
    Bamuqabel, Aya O.
    Alqurain, Zainab
    Dahlan, Dana
    Wasaya, Hanan I.
    Al Saedi, Ziyad S.
    Alqarni, Gutaybah S.
    Alqarni, Danah
    Ghalimah, Bayan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [2] Altziebler J., 2017, Saf. Health, V3, P12, DOI [10.1186/s40886-017-0063-8, DOI 10.1186/S40886-017-0063-8]
  • [3] Arora R, 2016, OPER ORTHOP TRAUMATO, V28, P30, DOI 10.1007/s00064-015-0434-4
  • [4] Barsky H.K., 1984, Guillaume Dupuytren: A Surgeon in His Place and Time
  • [5] Unite Rhumatologique des Affections de la Main (URAM) Scale: Development and Validation of a Tool to Assess Dupuytren's Disease-Specific Disability
    Beaudreuil, Johann
    Allard, Anne
    Zerkak, Djamila
    Gerber, Robert A.
    Cappelleri, Joseph C.
    Quintero, Nathaly
    Lasbleiz, Sandra
    Bernabe, Brigitte
    Orcel, Philippe
    Bardin, Thomas
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 (10) : 1448 - 1455
  • [6] Patient's perspective of treatment in Dupuytren's Disease: collagenase versus limited fasciectomy
    Beecher, Suzanne M.
    Wilkinson, Jordan E.
    Cuggy, Conor
    O'Shaughnessy, Michael
    [J]. JOURNAL OF HAND SURGERY-EUROPEAN VOLUME, 2022, 47 (11) : 1172 - 1174
  • [7] Belusa L, 1995, Handchir Mikrochir Plast Chir, V27, P272
  • [8] Bundesausschuss G., 2012, Bundesanzeiger
  • [9] Chen Neal C, 2011, Hand (N Y), V6, P250, DOI 10.1007/s11552-011-9326-8
  • [10] Collagenase and the Treatment of Dupuytren Contracture: Efficacy of Treatment and Patient Satisfaction
    Clesham, Kevin
    Sheridan, Gerard A.
    Murphy, Evelyn P.
    O' Connor, Sharon P.
    O' Sullivan, Michael E.
    [J]. JOURNAL OF HAND SURGERY-ASIAN-PACIFIC VOLUME, 2022, 27 (01) : 141 - 147